Loading... please wait

The Horizon Prize – Award Presentation | Main Stage

Programming Sponsor:

horizon clear e1635279491740 - The Horizon Prize - Award Presentation | Main Stage

Programming partner:

MIT Solve e1635279544358 - The Horizon Prize - Award Presentation | Main Stage


Patrick Diamond,, Lead for The Horizon Prize, MIT Solve
Holly Copeland, Senior Director for Corporate Social Responsibility, Sustainability, and Impact, Horizon Therapeutics
David Jacob, CEO, ThinkGenetic
Sandro Morganella, Head of Artificial Intelligence, Congenica

It takes an out-of-the-box initiative to improve treatment access for those who suffer from rare diseases. More than 7,000 rare diseases affect 400 million people worldwide who often cannot access the healthcare they need, according to Holly Copeland. Technology provides new hope.

Horizon Therapeutics launched the Horizon Prize with MIT Solve to seek solutions that would leverage data and analytics in order to do the following: improve the detection and diagnosis of rare diseases; promote community and connection among patients and their advocates; address the unjust and disproportionate burden of rare diseases faced by disinvested communities and historically-underrepresented identity groups; and, unlock collaboration by patients, scientists, and healthcare providers to improve patient outcomes.

These innovations deliver more personalized and effective pathways to diagnosis and treatment for people with rare diseases.

Patrick Diamond

It is great to see rare diseases gaining world-wide awareness. We know that providing a timely diagnosis for a patient can be life changing. We know that we need to invest in underserved communities to mitigate the injustice in healthcare access. With this prize we do have the opportunity to make a difference and we will.

Sandro Morganella

Key takeaways & next steps:

  • There remains a tremendous market opportunity to assist the 400 million people worldwide with rare diseases. Improving health equity through technology is not only the right thing to do, but it makes good business sense too.
  • The Horizon Prize was awarded to ThinkGenetic Inc. and Congenica. The winners will share a $150,000 prize.